2016 Hematological Malignancies

HD10: Second Neoplasia

10-year estimate [95%-CI]

4ABVD+30Gy 8.4% [4.6% to 12.3%] 4ABVD+20Gy 6.3% [2.8% to 9.8%] 2ABVD+30Gy 7.5% [3.7% to 11.3%] 2ABVD+20Gy 8.9% [4.8% to 13.0%]

298 Median observation time 98 months 233 93 15

 No difference in SIR for any SN: A= 2.1, B= 1.5, C= 1.6, D= 2.1 compared to the age- and sex-specific incidence in the German general population